What brokers are saying about Sun Pharmaceutical Industries

What brokers are saying about Sun Pharmaceutical Industries

Article image

When it comes to looking for stock market investment ideas, broker recommendations can be a useful place to start. These city experts tend to know the companies they cover inside-out, so their views can be valuable. They're even more valuable when you take into account the overall view of all the analysts that cover a stock.

Take Sun Pharmaceutical Industries (NSI:SUNPHARMA) as an example. Shares in the company have risen by 2.23% over the past month and they are currently trading at 623.6. But what do the analysts that cover the company think?

Based on the broker 'consensus', there could be reasons to believe that the positive recent trend will continue. In terms of trading recommendations, Sun Pharmaceutical Industries currently has:

  • 14 Buy recommendations
  • 1 Hold recommendations
  • 1 Sell recommendations

This suggests that analysts are generally upbeat about the outlook.

At its current price of 623.6, shares in Sun Pharmaceutical Industries are trading at a discount of -2.12% to its 52 week high price. The 1-year performance of the shares has been 47.3%.


While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Sun Pharmaceutical Industries it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Sun Pharmaceutical Industries that you can find out about here.


About us

Stockopedia helps individual investors make confident, profitable choices in the stock market. Our StockRank and factor investing toolbox unlocks institutional-quality insights into thousands of global stocks. Voted “Best Investment Research Tools” and “Best Research Service” at the 2021 UK Investor Magazine awards.

Sun Pharmaceutical Industries's StockRank™

High FlyerConservative

Sun Pharmaceutical Industries's StockRank™

With a StockRank of 85, Sun Pharmaceutical Industries is more attractive than 85% of the 14,655 stocks we cover in Asia, according to our proprietary ranking system.

See the full StockReport

Absolutely Perfect

"Trialed multiple other platforms - this is by far my favourite. Other platforms do not even have half the stuff that you can find on Stockopedia. Love it!"

As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.